CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Purpose of the study was to assess the effect of enzalutamide on time to Prostate Specific Antigen (PSA) progression as compared to placebo ...
Phase 3
Taipei, Taiwan and 46 other locations
Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...
Phase 1
Taipei, Taiwan and 48 other locations
therapy in participants with metastatic castration resistant prostate cancer (mCRPC). There will be ten cohorts in this study: Coho...
Phase 1, Phase 2
Taipei, Taiwan and 29 other locations
The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...
Phase 2
Taipei, Taiwan and 225 other locations
The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...
Phase 3
Taipei, Taiwan and 388 other locations
to radiographic progression-free survival (rPFS) per 1) Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 for soft tissue and/or Prostate...
Phase 3
Taipei, Taiwan and 322 other locations
To evaluate the effect of MCS® compared with placebo in reducing the risk of biopsy-detectable prostate cancer in high-risk subject...
Phase 2
Taipei, Taiwan
plus docetaxel in participants with metastatic castration resistant prostate cancer (mCRPC), all participants will receive the doce...
Phase 3
Taipei, Taiwan and 250 other locations
in participants with high-risk, localized or locally advanced prostate cancer receiving primary radiation therapy (RT) results in a...
Phase 3
Taipei, Taiwan and 271 other locations
The purpose of this study was to evaluate the efficacy of enzalutamide plus androgen deprivation therapy (ADT) as measured by radiographic progressio...
Phase 3
Taipei, Taiwan and 202 other locations
Clinical trials
Research sites
Resources
Legal